COMP360

Articles tagged with “COMP360”

2 articles

Compass Pathways: Extra COMP360 Dose Extends Relief to 1 Year

Compass Pathways reports 52-week open-label data from its COMP005 trial showing a second COMP360 psilocybin dose extended benefit. Here's what patients should know.

Sep 10, 2026

Read

news

COMP360 Phase 3 Data Confirms Rapid TRD Relief

Six-month data from a second Phase 3 trial of COMP360 psilocybin confirms rapid antidepressant effects for treatment-resistant depression. What patients should know.

Jul 8

Back to all articles

Need help or want to reach readers?

Have a correction, provider question, or advertising inquiry? Reach the editorial team.

Contact the site